Diagnosis

Jaundice

Yellowing of the skin and sclera due to an elevation in total bilirubin > 2.5-3 mg/dl or > 43-51 μmol/L.

Also known as: Hyperbilirubinemia, Icterus

Etiology

Cause [r4a]

  1. Prehepatic unconjugated: increased bilirubin production

    • Hemolysis: blood group incompatibilities, RedBloodCell defects (Sickle-cell anemia, Spherocytosis, Thalassemia, G-6-PD-deficiency, Pyruvate kinase deficiency), Hemolytic–uremic syndrome, intracranial hemorrhage, polycythemia, sepsis

    • Gilbert syndrome

    • Crigler-Najjar syndrome

    • Neonatal jaundice (immature metabolism of bilirubin, clearance is compromised)

  2. Hepatic conjungated/unconjungated: decreased bilirubin metabolism/clearance

    • Cirrhosis

    • Viral Hepatitis

    • Alcoholic liver disease

    • Cholestatic liver disease: Primary biliary cholangitis, Primary sclerosing cholangitis

    • Hepatotoxicity / Drug-induced liver injury: sulfa, ceftriaxone, penicillins, oral contraceptives, rifampin, probenecid, steroids, chlorpromazine, herbal medications, arsenic

    • Gilbert syndrome (prevalence ~5%)

    • Crigler–Najjar syndrome

    • Hypothyroidism and cretinism (congenital hypothyroidism)

    • Leptospirosis

    • Infiltrative diseases: Amyloidosis, lymphoma, sarcoidosis, tuberculosis

    • Total parenteral nutrition

    • Intestinal obstruction and pyloric stenosis

  3. Posthepatic conjungated (elevated ALP): impaired/obstructed hepatobiliary flow

    • Gallstones: Choledocholithiasis, Mirizzi's syndrome

    • Cancer: Pancreatic cancer, Cholangiocarcinoma, Hepatocellular carcinoma

    • Cysts: Choledochal cysts, Pancreatic pseudocysts

    • Cholestasis of pregnancy

    • Pancreatitis

    • Infection: syphilis, toxoplasmosis, HIV, CMV, herpes virus, rubella, parasite (liver flukes)

    • Congenital: Biliary atresia, Alagille syndrome, alpha-1 anti-trypsin deficiency, galactosemia, fructosemia, Tyrosinemia type 1, cystic fibrosis, progressive familial intrahepatic cholestasis, Aagenaes syndrome, Dubin-Johnson syndrome, bile acid synthesis disorders, Rotor's syndrome

Pathophysiology [r4a]

  1. Prehepatic phase --> Production of bilirubin:

    • Heme (released by senescent or defective RBCs) --> Biliverdin --> Bilirubin

  2. Hepatic phase:

    • Unconjugated (non-soluble) bilirubin --> conjugation to glucuronic acid in the hepatocytes resulting in conjugated bilirubin, which is soluble in the bile

  3. Posthepatic phase:

    • Conjugated bilirubin --> bile canaliculi --> bile ducts --> gallbladder --> ampulla of Vater --> colonic bacteria deconjugate: bilirubin --> urobilinogen

      • 80% excreted into the feces (stercobilin)

      • 10-20% into the enterohepatic circulation

      • ~5% renal excretion (the yellow pigment of urine)

Complication [r4a]

Epidemiology

Incidence per 100.000 [kek][hge][wog]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Acholia, Anorexia, Dark urine, Fatigue, Fever, Hepatomegaly, Icterus, Nausea, Pruritus, Spider nevus, Vomiting, Weight loss

Clinical findings

Anemia, Bile duct dilation, Bilirubinuria, Cholestasis, Decreased Haptoglobin, Elevated ALAT, Elevated ALP, Elevated ASAT, Elevated Bilirubin, Elevated GGT, Elevated Lactic Dehydrogenase, Jaundice

Anamneses

None listed.

Localized findings

Pain
Radiates
RUQ (Right Upper Quadrant)
Onset
Gradual (days)
Pattern
Constant
Severity
Mild (1-3)Moderate (4-7)
Swelling
Radiates
Abdomen
Onset
Gradual (days)
Pattern
ConstantIncreasing

Approach

Treatment

Treatment of the underlying cause: [r4a]

  1. Symptomatic:

    • Pruritus: warm baths, oatmeal baths, antihistamine, bile acid sequestrant

  2. Physiologic jaundice: Phototherapy of the newborn

  3. Autoimmune hemolysis: Intravenous immunoglobulin, exchange transfusion

  4. Bile duct blockage:

    • Bile duct stent (ERCP, PTC)

    • Kasai

    • Resection of pancreas, liver or bile ducts

    • Liver transplantation

Differential diagnoses

Acute pancreatitis, Alcoholic liver disease, Autoimmune hepatitis, Biliary atresia, Cholangiocarcinoma, Choledochal cysts, Choledocholithiasis, Cholelithiasis, Cirrhosis, Crigler-Najjar syndrome, Cytomegalovirus, Drug-induced liver injury, Gilbert syndrome, Hemolysis, Hemolytic anemia, Hypothyroidism, Intestinal atresia, Neonatal hepatitis, Nonalcoholic fatty liver disease, Pancreatic cancer, Primary biliary cirrhosis, Pyloric stenosis, Toxoplasmosis, Viral hepatitis, Wilson's disease


References

[1] Joseph A, Samant H. Jaundice. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): https://www.ncbi.nlm.nih.gov/books/NBK544252/

[2] Nasr P, von Seth E, Mayerhofer R, Ndegwa N, Ludvigsson JF, Hagström H. Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019. Eur J Epidemiol. 2023 Sep;38(9):973-984.

[3] Hansen TWR. Narrative review of the epidemiology of neonatal jaundice. Pediatr Med 2021;4:18.

[4] Taylor A, Stapley S, Hamilton W. Jaundice in primary care: a cohort study of adults aged >45 years using electronic medical records. Fam Pract. 2012 Aug;29(4):416-20.

[5] Björnsson E, Gustafsson J, Borkman J, Kilander A. Fate of patients with obstructive jaundice. J Hosp Med. 2008 Mar;3(2):117-23.

[6] http://emedicine.medscape.com/article/178841 (2014-01-02); [Medscape]

[7] http://emedicine.medscape.com/article/178757 (2014-01-02); [Medscape]

[8] Ansong-Assoku B, Shah SD, Adnan M, et al. Neonatal Jaundice: https://www.ncbi.nlm.nih.gov/books/NBK532930/

Scroll to top